370 results on '"Schulenburg, Johann"'
Search Results
2. Nachhaltige Vergütung der B‑Zentren für Seltene Erkrankungen in Deutschland – Status quo und Lösungsansätze
3. Age- and gender-based comorbidity categories in general practitioner and pulmonology patients with COPD
4. Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries
5. Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors
6. Risiko
7. Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments
8. HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
9. Affirmative and silent cyber coverage in traditional insurance policies : Qualitative content analysis of selected insurance products from the German insurance market
10. Real-world evidence for coverage determination of treatments for rare diseases
11. Influencing factors for the digital transformation in the financial services sector
12. Correction to : An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies
13. Digital Transformation in Back-Offices of German Insurance Companies
14. An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies
15. Herausforderungen und Implikationen für das Cyber-Risikomanagement sowie die Versicherung von Cyberrisiken – Eine empirische Analyse
16. Health-Related Genetic Direct-to-Consumer Tests in the German Setting : The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System
17. Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal
18. A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany
19. The evolution and dynamics of male-killing in the two-spot ladybird, Adalia bipunctata L. (Coleoptera: Coccinellidae)
20. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe
21. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe
22. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
23. Social/economic costs and quality of life in patients with haemophilia in Europe
24. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe
25. Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe
26. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
27. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
28. Social/economic costs and health-related quality of life in patients with scleroderma in Europe
29. Risikobeurteilung/Risikoethik
30. Risiko
31. Impact of electrically assisted bicycles on physical activity and traffic accident risk: a prospective observational study
32. 3. Prozessschritte
33. 6. Datenvalidierung
34. 4. Studienkonzeption
35. Literaturverzeichnis
36. 2. Grundlagen und Methodik
37. 1. Einleitung und Motivation
38. 7. Datenaufbereitung und -analyse
39. 5. Datenextraktion und Aufgreifkriterien
40. 8. Publikation und Limitationen
41. Titelei/Inhaltsverzeichnis
42. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
43. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe
44. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
45. Social/economic costs and health-related quality of life in patients with scleroderma in Europe
46. Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe
47. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe
48. Social/economic costs and quality of life in patients with haemophilia in Europe
49. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
50. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.